In a new clinical trial, evidence was provided that a new way of treating multiple sclerosis (MS) could be more effective than present therapies. In the trial, high-dose immunosuppressive therapy was performed on the patient and followed with transplanting the patient own blood-forming stem cells back into them. This resulted in the patient experiencing a sustainable remission in the disease, which causes the central nervous system to be attacked by the immune system.
The results of the trial showed that 69& of the participants had survived for the 5 year length of the study with no relapse in their symptoms. None of the patients took any other MS medicines during the study. The trial was sponsored by the National Insitute of Allergy and Infectious Diseases.
Among the symptoms that MS patients experience are chronic pain, weakness, motor and speech difficulties, and fatigue. It is common that people who suffer from the disease will have periods with no to mild symptoms and then experience flare-ups. As the disease progresses the flare-ups tend to occur more often and get more pronounced.
A doctor that has extensive experience with multiple sclerosis patients in Dr. Shiva Vasishta. Dr. Shiva Vasishta is a practicing Neurologist and is affiliated with the Kennedy Health System Cherry Hill Campus in Cherry Hill, New Jersey. He practices at Eastern Neurodiagnostic Associates. His specialties are Neurology and Psychiatry and he has worked with MS patients for over 30 years.
Dr. Shiva Vasishta graduated from Government Medical College in 1979 with a Doctor in Medicine. Dr. Shiva Vasishta served his Residency at Boston Medical Center and attained a Fellowship at Tufts Medical Center. He is also Board Certified in Neurology.